Gain Therapeutics Company
Gain Therapeutics is a biotech company developing pharmacological chaperones drugs designed to treat rare metabolic disorders.
Industry:
Early Drug Development, Preclinical Development
Headquarters:
Bethesda, Maryland, United States
Founded Date:
2017-01-01
Employees Number:
11-50
Funding Status:
IPO
Investors Number:
6
Total Funding:
14396508
Estimated Revenue:
Less than $1M
Last Funding Date:
2020-07-21
Last Funding Type:
Series B
Register and Claim Ownership